Prasad Sanjay Dhiwar

7PUBLICATIONS
19CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsTraditional Chinese medicine and treatmentsMolecular targetsHuman impacts of climate change and human adaptationBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 21, 2025
In-silico based discovery of potential Keap1 inhibitors using the strategies of pharmacophore screening, molecular docking, and MD simulation studies.

Ekta Singh, Gurubasavaraja Swamy Purawarga Matada, Prasad Sanjay Dhiwar

|May 09, 2023
An assessment of EGFR and HER2 inhibitors with structure activity relationship of fused pyrimidine derivatives for breast cancer: a brief review.

Prasad Sanjay Dhiwar, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal

|Nov 23, 2021
Discovery of potential Aurora-A kinase inhibitors by 3D QSAR pharmacophore modeling, virtual screening, docking, and MD simulation studies.

Gurubasavaraja Swamy P M, Nahid Abbas, Prasad Sanjay Dhiwar

|Aug 10, 2021
Management of COVID-19-induced cytokine storm by Keap1-Nrf2 system: a r eview.

Ekta Singh, Gurubasavaraja Swamy Purawarga Matada, Nahid Abbas

Pageof 2